Tuesday, March 23, 2021 4:29:32 PM
Dr Chang is listed as the CEO as of an article from 2020
They renewed Patents very recently
They're a MicroCap very small Biotech that is likely barely operating or is a tax shelter for Dr Chang
Supposedly, and I can't confirm this , they are currently "working on" molecules but other bigger Biotechs are working on the same ones.
The consensus is that they renewed patents to get the whole MultiCell package ready to sell to a larger Biotech that just wants these Toll Cell Receptor patents. A big Biotech could probably just buy MCET without even breaking a sweat.
I'm only 500,000 shares deep so this is a gamble for me. If it tanks I'll be ok lol
Do your Due Diligence and if you don't like what you see then don't go in.
Some people here are 25milly shares in.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM